Please login to the form below

Not currently logged in
Email:
Password:

Former Langland exec joins DJM Unlimited

Michael Le Brocq becomes the firm’s new director

Michael Le Brocq DJMDJM Unlimited has appointed Michael Le Brocq as its new board director.

Le Brocq has 20 years' experience in healthcare communications gained client-side, in start-ups and within agencies.

Most recently he led the ethical business unit at Langland, with responsibility for all of the agency's pharmaceutical clients; prior to that he was head of strategy at ICC Lowe.

Following a succession of new account wins, DJM said his new role will be to drive the continued growth of DJM Unlimited within the health and wellness category, providing strategic and business development support to the planning and account teams in London and New York.

He will work alongside Dominic Marchant, MD and founder of DJM Unlimited.

Le Brocq said: “I'm thrilled to be joining Dominic and the team at DJM Unlimited, it's a rare opportunity to be part of a forward-thinking agency enjoying explosive growth by breaking the mould of what digital means in healthcare.”

Meanwhile, former Director Mark Hartley, has become head of  DJM Unlimited's sister agency Plastic Unlimited, a digital experiential and motion graphics creative agency focusing more on the consumer/retail client base.

1st July 2015

From: Marketing

Share

Tags

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Attigo (part of the Mednet Group)

Inclusion drives innovation. Attigo, a social enterprise, helps pharma and the socially conscious business shape the future by engaging with...

Latest intelligence

Are patient recruitment and retention rates rising or falling?
First up, the good news. Over the past seven years, clinical trial recruitment rates have been on the rise....
Could formulary intelligence be your brand differentiator?
Proprietary research, and the COVID-19 experience, shows how formulary intelligence can drive competitive advantage at launch...
Lara Meyer
How COVID-19 is accelerating the threat of antimicrobial resistance
Why antimicrobial resistance needs to be addressed with the same urgency as COVID-19...

Infographics